Results 241 to 250 of about 72,150 (302)

Pharmacogenomics Applied to Acute Leukemias: Identifying Clinically Relevant Genetic Variants. [PDF]

Biomedicines
Pessoa FMCP, Farias IM, Nogueira BMD, Machado CB, Barreto IV, Machado AKDC, de Morais GP, da Cunha LS, de Sousa Oliveira D, Thé AP, Ribeiro RM, Thé PMP, Moraes Filho MO, Moraes MEA, Moreira-Nunes CA.   +14 more
europepmc   +1 more source

Real-World Utilization of Midostaurin in Combination with Intensive Chemotherapy for Patients with <i>FLT3</i> Mutated Acute Myeloid Leukemia: A Multicenter Study. [PDF]

J Clin Med
Seçilmiş S, Kabukçu Hacıoğlu S, Hindilerden F, Turgut B, Özatlı D, Akgün Çağlıyan G, Baştürk A, Yüksel Öztürkmen A, Katırcılar Y, Namdaroğlu S, Ünver Koluman B, Sunu C, Korkmaz S, Uysal A, Bilen Y, Erkurt MA, Dal MS, Ulaş T, Altuntaş F.   +18 more
europepmc   +1 more source

A case report on a patient with acute lymphoblastic leukaemia, with unusual side effects, using the intravenous route for administration of cytarabine versus the subcutaneous route

Amit Kumar Verma, Sheikh Sabat, Ravi Kumar Parihar, Sanjeev Kumar Digra   +3 more
openalex   +1 more source

Effectiveness and safety of orelabrutinib combined with rituximab, temozolomide, methotrexate, and cytarabine in intensive chemotherapy-unfit patients with PCNSL in China. [PDF]

Eur J Med Res
Fang Z, He F, Gong J, Liu J, Wang X, Ling H, Liu J, Zou Z, Liang C, Liu L.   +9 more
europepmc   +1 more source

Log Rank Test for AML patients on supportive care alone versus AML patients on treatment with LD cytarabine/LD cytarabine + venetoclax or intensive chemotherapy in addition to supportive care.

Michelle Munroe (22279122), Clara Chamba (19176255), Mbonea Yonazi (22279125), Samira Mahfudh (22279128), William Mawalla (22279131), Kelvin Mbelekwa (22279134), Gladys Kaaya (22279137), Rebbecca Mwakichako (22279140), Johnson Mshiu (15282989), Magdalena Lyimo (22279143), Mwashungi Ally (22279146), Ahlam Nasser (16859163)   +11 more
openalex   +1 more source

Salvage therapy with etoposide and mitoxantrone in patients with refractory acute myeloid leukemia: a retrospective cohort study. [PDF]

Ann Med Surg (Lond)
Mirzania M, Khajeh-Mehrizi A, Yavari T, Safaei Nodehi SR, Roudini K, Rashidian H, Danandeh K, Tayyari P.   +7 more
europepmc   +1 more source

cellMCD Effectively Discovers Drug Resistance and Sensitivity Genes for Acute Myeloid Leukemia. [PDF]

Genes (Basel)
Obodo D, Nguyen NHK, Cao X, Parcha PK, Vulpe CD, Lamba JK, Pounds SB.   +6 more
europepmc   +1 more source

Case report and literature review of pleural myeloid sarcoma. [PDF]

Medicine (Baltimore)
Wang X, Liu J.
europepmc   +1 more source

Supplementary Table S3 from Cladribine Added to Idarubicin and Cytarabine as an Induction Regimen for Patients with <i>De Novo</i> Acute Myeloid Leukemia: A Multicenter, Randomized Phase III Trial

Xiang Zhang, Yue Han, Huiying Qiu, Myat Min Han, Aining Sun, Shengli Xue, Zhengming Jin, Miao Miao, Ying Wang, Chengcheng Fu, Xiaowen Tang, Suning Chen, Caixia Li, Lian Bai, Zhihong Lin, Jun Chen, Haohao Han, Jia Chen, Depei Wu   +18 more
openalex   +1 more source

Safety and efficacy of venetoclax-azacitidine combined with low-dose Idarubicin and cytarabine regimens for the treatment of newly diagnosed acute myeloid leukemia patients compared to the standard chemotherapy: a propensity score-matched real-world single-center experience. [PDF]

Ann Hematol
Chen XT, Li Q, Zhao YQ, Fan SJ.
europepmc   +1 more source